Bethlehem, Pa.-based TB Biosciences has obtained $1.5 million in Series A financing, which will go toward the company's product-development activities and clinical studies. The company is working on a point-of-care assay for diagnosing tuberculosis using proteins found in people with active TB.
Funding round pulls in $1.5M for TB Biosciences
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan